Skip to content

Clinical trials

Phase 4 Anxiety Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anxiety Disorders Phase: Phase 4 Clear all

171 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20023
20035
20046
20057
200610
20076
20085
20099
201011
20116
20125
20137
20149
20158
20163
201711
20187
20199
20205
20218
20226
20237
20242
20256
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed112
Unknown status20
Recruiting16
Terminated12
Withdrawn6
Not yet recruiting4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital11
Medical University of South Carolina3
Second Affiliated Hospital of Wenzhou Medical University3
University of California, San Diego3
University of Cincinnati3
University of Pennsylvania3
University of Pittsburgh3
Chinese PLA General Hospital2
Creighton University2
Erasmus Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anxiety Disorders171
Generalized Anxiety Disorder26
Major Depressive Disorder16
Pain14
Panic Disorder13
Stress Disorders, Post-Traumatic12
Phobia, Social9
Sleep Initiation and Maintenance Disorders8
Obsessive-Compulsive Disorder6
Bipolar Disorder5

Trials

Showing 1 to 25 of 171. Each trial links to its page on Pharma Observatory.

71 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.